Data / Form D filings / Candesant Biomedical, Inc.
Candesant Biomedical, Inc.: Form D filings
Candesant Biomedical, Inc., a health care company in Nashville, TN, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on June 6, 2023, reports $35.4 million sold of a $35.4 million offering to 59 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1718 Church Street # 1458, Nashville, TN, 37203
- Phone
- (415) 726-4888
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1802148
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2023 | New notice | $35,360,875 | $35,360,875 | 59 | Apr 12, 2022 | sec.gov | |
| Feb 18, 2020 | New notice | $9,133,432 | $9,133,432 | 33 | Feb 5, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Karen L. Long | Director | |
| Brad L. Hauser | Director | |
| Niquette L. Hunt | Executive Officer, Director | |
| Mary Beth L. Kreissler | Executive Officer | |
| Samara L. Braunstein | Director | |
| Michael L. Kane | Director | |
| Eileen L. McGuire | Director |
Other health care companies in Tennessee that filed recently
- OmniBuds, Inc. $3 million · Oct 21, 2026
- MODEL ONCOLOGY, LLC $10.9 million · Oct 19, 2026
- AngelEye Health, Inc. $10 million · Sep 24, 2026
- Winter Innovations, Inc. $1.3 million · Sep 1, 2026
- Better Place Wellness Co $50,000 · Aug 24, 2026
Every Form D from the week of Jun 5, 2023 · All recent filings in Tennessee · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Candesant Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.